id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2460493,d8e031b5-0ff6-41b6-bb48-24b7f767ba1f,Q2,ATLAS ADVOCACY,401100069,BLADDER CANCER ADVOCACY NETWORK,2020,second_quarter,MED,CDMRP; Disease Awreness resolution,"HOUSE OF REPRESENTATIVES,SENATE",9000,,0,0,2020-06-30T17:47:33.907000-04:00
2460551,fc55f948-2c7a-4858-bea5-8c3328c308a8,Q2,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2020,second_quarter,MED,Issues and legislation related to Alzheimer's disease research,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2020-07-01T09:24:56.350000-04:00
2460554,14d31ff7-3a95-46a0-8c15-96f518926e6a,Q2,"FRANCIS EDWARD & CRONIN, INC.",311314,"PATH DECISION SUPPORT SOFTWARE, LLC",2020,second_quarter,MED,Issues and legislation related to diabetes treatment and diagnosis,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-01T09:28:57.497000-04:00
2460589,dcbda974-40a7-47bc-9cf9-007552cec98c,Q2,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,PPLA,2020,second_quarter,MED,Pharmaceutical labeling,Food & Drug Administration (FDA),18700,,0,0,2020-07-01T11:00:10.853000-04:00
2460629,25ddcbe8-78f9-4e22-a459-6f2ae6de4584,Q2,OTT BIELITZKI & O'NEILL PLLC,401103584,BIOPORTO DIAGNOSTICS A/S,2020,second_quarter,MED,Educating officials about a health care diagnostic tool.,"Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2020-07-01T13:15:27.487000-04:00
2460948,a113613d-0485-4f6a-8d13-d77cc3f0dd74,Q2,BALLARD PARTNERS,401104288,"ORIGIN LOGISTICS, LLC",2020,second_quarter,MED,Issues related to diagnostic testing for COVID-19.,"Health & Human Services, Dept of (HHS)",40000,,0,0,2020-07-02T17:29:34.363000-04:00
2461070,f17498ae-9e5b-48c3-8b3f-92b59868149d,Q2,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2020,second_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2020-07-03T11:59:32.487000-04:00
2461404,bf3759e8-2a87-4dc6-91d2-a99e667e0f1d,Q2,ISEMAN & ASSOCIATES LLC,401103582,"TICHENOR VENTURES, LLC",2020,second_quarter,MED,Monitoring biotech legislation,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2020-07-06T14:03:24.150000-04:00
2461453,adfa0837-e0db-424b-b4b4-56933b6e3227,Q2,MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE),400265214,MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE),2020,second_quarter,MED,"Funding for COVID treatments and research
Funding of federally-sponsored research
Congressional oversight of federally-sponsored research
Indirect cost reimbursement for federally-sponsored research
H.R. 3038, ""Securing American Science and Technology Act"" - provisions related to establishing a system for addressing concerns about foreign influence on research","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,201000,0,0,2020-07-06T15:00:20.730000-04:00
2461457,2c27239c-ccdc-418f-9b05-426b193bd3b2,Q2,RUSSELL PUBLIC COMMUNICATIONS,401104398,DIGITAL PATHOLOGY ASSOCIATION,2020,second_quarter,MED,"Urge CMS waiver, in view of pandemic response, to permit remote digital pathology sign-offs","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,White House Office",10000,,0,0,2020-07-06T15:13:50.277000-04:00
2461517,868d4579-8f39-4f7b-a7c8-845e4a6e23f5,2A,MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE),400265214,MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE),2020,second_quarter,MED,"Funding for COVID treatments and research
Funding of federally-sponsored research
Congressional oversight of federally-sponsored research
Indirect cost reimbursement for federally-sponsored research
H.R. 3038, ""Securing American Science and Technology Act"" - provisions related to establishing a system for addressing concerns about foreign influence on research","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,201000,0,0,2020-07-06T18:00:28.370000-04:00
2461530,651d65d3-4789-4a9f-b940-3ef976fe8e31,Q2,"THE PETRIZZO GROUP, INC.",305932,ACCESS TO ADVANCED HEALTH INSTITUTE,2020,second_quarter,MED,Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; support adjuvant inclusion in COVID-19 countermeasures.,"Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2020-07-06T19:40:28.183000-04:00
2461554,61c61d87-0787-4eec-9f92-43dac4190662,Q2,MUNK POLICY & LAW,401105075,SOUTHERN METHODIST UNIVERSITY,2020,second_quarter,MED,Traumatic Brain Injury Research,"HOUSE OF REPRESENTATIVES,SENATE,U.S. Geological Survey (USGS)",30000,,0,0,2020-07-06T22:48:42.217000-04:00
2461627,370193c2-281b-4443-827d-007bdb2d6238,Q2,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2020,second_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2020-07-07T04:42:14.807000-04:00
2461734,002629c7-839c-4898-a714-38b45e762876,Q2,WATKINS & EAGER PLLC,401104403,NATIONAL FRAGILE X FOUNDATION,2020,second_quarter,MED,Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers.  Encourage Members to act favorably on matters of interest related to funding & research.,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2020-07-07T12:00:23.510000-04:00
2461794,0dff3624-1084-4393-9995-6ca95f402ae5,Q2,"CONGRESSIONAL SOLUTIONS, INC (CSI)",297237,UNIVERSITY OF NORTH TEXAS SYSTEM,2020,second_quarter,MED,COVID19 Research,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2020-07-07T13:20:58.287000-04:00
2461850,32ee8af9-48fb-44d7-83fe-7dd10ef03fae,Q2,BLUEBIRD STRATEGIES,401105447,"MYRIAD GENETICS, INC.",2020,second_quarter,MED,Legislation to regulate clinical labs under CLIA and FDA.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-07T14:13:34.257000-04:00
2461854,fb598e50-07a4-4122-9334-2b2e1eb73d02,Q2,BLUEBIRD STRATEGIES,401105447,MYOTONIC,2020,second_quarter,MED,Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2020-07-07T14:15:38.380000-04:00
2461977,2d7472b9-8107-4f6e-ae3b-419160d9a9c5,Q2,"AUBURN HEALTH STRATEGIES, LLC",292697,"NEUROTECH, LLC",2020,second_quarter,MED,EEG monitoring,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-07T15:40:06.220000-04:00
2462070,63a45a46-548e-4850-a950-07cc0f11b188,Q2,SQUIRE PATTON BOGGS,30906,"LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC.",2020,second_quarter,MED,Funding support for federally qualified health centers; reauthorization of programs,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2020-07-07T16:25:04.657000-04:00
2462510,b29daada-d5c5-4cf4-bd5c-94626beef28b,2T,WINNING STRATEGIES WASHINGTON,50796,"RISING PHARMA HOLDINGS, INC.",2020,second_quarter,MED,Distribution of generic pharmaceutical products,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,1,2020-07-08T14:18:22.133000-04:00
2462612,f063f5f7-85e8-4c3f-9876-dbf78ddcccb3,Q2,"THE CORMAC GROUP, LLC",66773,KESSLER FOUNDATION,2020,second_quarter,MED,"Appropriations, DOD, TBI research, Veterans Issues","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-08T17:20:33.833000-04:00
2462759,3b3bc387-59c3-4806-8797-66053ee41d6a,2A,BEN BARNES GROUP LP,5415,ENVIGO RMS LLC,2020,second_quarter,MED,Medical/Disease Research,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2020-07-09T10:12:12.623000-04:00
2462825,8480ae8e-18ff-4626-97e7-81e06960282e,Q2,SQUIRE PATTON BOGGS,30906,ALLIANCE FOR BIOSECURITY,2020,second_quarter,MED,Preparedness and response as it relates to Biosecurity.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2020-07-09T11:24:54.103000-04:00
2462943,e61f3968-44e1-4c53-8967-6db6eed3a060,2T,"THE LIVINGSTON GROUP, LLC",49635,50 CITIES INC,2020,second_quarter,MED,Infectious disease prevention.,,20000,,0,1,2020-07-09T13:03:36.403000-04:00
2462985,921dfe17-d940-4c9c-8035-afc3f1fdca0c,Q2,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2020,second_quarter,MED,Labor/HHS/Education Appropriations: Provisions relating to disease research.,"Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2020-07-09T13:28:10.947000-04:00
2463035,77cb75d0-b5e1-450d-8852-2da0713e79a0,Q2,KUTAK ROCK LLP,21962,NE ENTERPRISES,2020,second_quarter,MED,Reauthorization of Pandemic and All Hazards Preparedness Act and related matters,,10000,,0,0,2020-07-09T14:00:51.290000-04:00
2463051,8ec0426b-98a3-4f8a-b238-8906549e6971,Q2,"THE PETRIZZO GROUP, INC.",305932,CEL-SCI CORPORATION,2020,second_quarter,MED,"Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in head and neck cancer with 928 patients enrolled. 
LEAPS COVID-19 Immunotherapyas a new immune-based treatment for COVID-19","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Vice President of the U.S.",50000,,0,0,2020-07-09T14:41:12.077000-04:00
2463062,92e2601e-399b-4e3f-a81d-0f1eb07c4261,Q2,"THE PETRIZZO GROUP, INC.",305932,OMEROS CORPORATION,2020,second_quarter,MED,Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",80000,,0,0,2020-07-09T14:49:19.820000-04:00
2463064,16060eb3-de11-4e0d-9051-09f01ca3f249,Q2,"THE PETRIZZO GROUP, INC.",305932,ALLEN INSTITUTE,2020,second_quarter,MED,"Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. The Human Projectome Project, a comprehensive Atlas of cell types in human brain and the Mouse Connectome Project for BRAIN Initiative","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2020-07-09T14:52:21.003000-04:00
2463127,f2edc2d2-21ae-4ec1-845e-68b0ef3b4dd1,Q2,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2020,second_quarter,MED,Funding for USDA ARS Human Nutrition Research Centers in the FY2021 House and Senate Agricultural Appropriations bills and finalizing funding for FY20,"HOUSE OF REPRESENTATIVES,SENATE",5000,,0,0,2020-07-09T21:37:10.690000-04:00
2463157,51f5e857-434c-454c-ab3b-d76c9956c234,Q2,SQUIRE PATTON BOGGS,30906,"IMPACT JOURNALS, LLC",2020,second_quarter,MED,National Library of Medicine indexing matters.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2020-07-10T09:42:41.437000-04:00
2463180,89fcf09b-e82f-499e-a6a4-8fc3f4fb6d1b,Q2,SQUIRE PATTON BOGGS,30906,NATIONAL CANNABIS ROUNDTABLE,2020,second_quarter,MED,"Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.","HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Treasury, Dept of,White House Office",80000,,0,0,2020-07-10T09:47:56.033000-04:00
2463256,ecbcd839-d274-42fd-a682-8cfab07bac11,Q2,THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH,314055,THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH,2020,second_quarter,MED,"Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense","HOUSE OF REPRESENTATIVES,SENATE",,69560,0,0,2020-07-10T10:58:58.117000-04:00
2463341,8f495fe9-5e7d-4eb9-ba1d-797fa3f1d086,Q2,GOLDBUG STRATEGIES LLC,400701094,COALITION FOR 21ST CENTURY MEDICINE,2020,second_quarter,MED,"in vitro diagnostics, clinical laboratories, digital health regulation","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",19000,,0,0,2020-07-10T12:04:39.177000-04:00
2463439,5019f127-520a-4e2d-a3b4-4f23a4a28190,Q2,THE JACKSON LABORATORY,401104723,THE JACKSON LABORATORY,2020,second_quarter,MED,"Issues pertaining to basic science research and biomedical research.
The background and use of animal models in biomedical research.
National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations. 
Issues pertaining to COVID-19 diagnosis and animal model discovery.","HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)",,30000,0,0,2020-07-10T13:43:06.773000-04:00
2463765,e08a0d9b-0096-4f30-9d8f-f3969077cd59,Q2,"REPUBLIC CONSULTING, LLC",401016871,IQVIA,2020,second_quarter,MED,Monitor Data and Science policy.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2020-07-11T12:50:40.997000-04:00
2463843,363005e6-8129-45db-87ff-98b0f746fe17,Q2,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2020,second_quarter,MED,"Funding for NIH research; H.R. 4159, PACT Act.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2020-07-12T14:54:54.687000-04:00
2464141,a637eea8-e326-4684-bdff-554c02a23742,Q2,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2020,second_quarter,MED,FY21 Department of Labor/HHS Appropriations bill,"Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,150000,0,0,2020-07-13T12:41:58.370000-04:00
2464370,0666268d-579e-4077-b8c5-7437ea0b16d9,Q2,STANFORD UNIVERSITY,36492,STANFORD UNIVERSITY,2020,second_quarter,MED,"HR748 
Coronavirus Aid Relief and Economic Security Act of 2020 

HR6800
Health and Economic Recovery Omnibus Emergency Solutions Act

Reciprocity of Licensing Standards for Health Care Practitioners and Professionals 

Health Professions Programs

Graduate Medical Education Funding

Pediatric GME Programs","Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS)",,90000,0,0,2020-07-13T15:35:54.017000-04:00
2464703,209c5d88-63c3-47fb-99be-296b69210e1f,Q2,AMERICAN PHYSICAL THERAPY ASSOCIATION,3093,AMERICAN PHYSICAL THERAPY ASSOCIATION,2020,second_quarter,MED,"NIH Rehab issues
APTA role with NIH
Traumatic brain injury research
Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions
NIH Research and Development funding
Physical Therapist role in childhood obesity
Relocate TBI State Grant Program to ACL
NIDILRR - Rehab research
Nomination to NIH Committees
Safety of Children in School (Restraint & Seclusion)
Falls and Falls Prevention
HR 7154 Outpatient Therapy Modernization and Stabilization Act","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office",,236490,0,0,2020-07-14T09:37:31.037000-04:00
2464735,413c57ce-e409-4d68-a212-11f20aeaabbc,2A,AMERICAN PHYSICAL THERAPY ASSOCIATION,3093,AMERICAN PHYSICAL THERAPY ASSOCIATION,2020,second_quarter,MED,"NIH Rehab issues
APTA role with NIH
Traumatic brain injury research
Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions
NIH Research and Development funding
Physical Therapist role in childhood obesity
Relocate TBI State Grant Program to ACL
NIDILRR - Rehab research
Nomination to NIH Committees
Safety of Children in School (Restraint & Seclusion)
Falls and Falls Prevention
HR 7154 Outpatient Therapy Modernization and Stabilization Act","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office",,236490,0,0,2020-07-14T09:53:36.907000-04:00
2464794,79b2f996-652d-46ab-9481-f4310d42cd27,Q2,MARSHFIELD CLINIC HEALTH SYSTEM,57830,MARSHFIELD CLINIC HEALTH SYSTEM,2020,second_quarter,MED,"General research support, health care quality improvement, precision medicine","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,70000,0,0,2020-07-14T10:46:53.967000-04:00
2464879,218f2d1b-8736-4a99-aac6-4e674989b80f,Q2,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,312496,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,2020,second_quarter,MED,"NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, 340B, surprise billing legislation, screening and enrollment issues, pediatric research bill HR4519 PACT Act, COVID related testing and research","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",,40560,0,0,2020-07-14T11:37:14.437000-04:00
2465144,9ea8a8ed-5dd1-49d9-8cf2-ce7fcfc57d01,Q2,TODD STRATEGY GROUP,401103321,"BIODESIX, INC.",2020,second_quarter,MED,FDA regulation of laboratory developed tests.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-14T14:10:29.973000-04:00
2465276,3165eda5-f6d9-4270-b2e5-e995db447e89,Q2,"K&L GATES, LLP",32098,NATIONAL ASSN FOR BIOMEDICAL RESEARCH,2020,second_quarter,MED,Issues related to medical research (no legislation).,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,Transportation, Dept of (DOT)",20000,,0,0,2020-07-14T14:59:19.093000-04:00
2465294,c05f8afd-2ed8-4351-be78-3812bde95964,Q2,TODD STRATEGY GROUP,401103321,ORGANIZE.ORG,2020,second_quarter,MED,Organ procurement policy.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-14T15:03:24.087000-04:00
2465766,90294512-29fc-429d-bc5f-420e7ec88e6e,Q2,MCDERMOTT+ LLC,401103287,COALITION FOR 21ST CENTURY MEDICINE,2020,second_quarter,MED,Issues concerning regulation of laboratory-developed tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",40000,,0,0,2020-07-15T10:08:42.967000-04:00
2465844,4bbbf2ef-ff4e-4d44-9970-248325ccbeee,Q2,WINNING STRATEGIES WASHINGTON,50796,I AM ALS,2020,second_quarter,MED,Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2020-07-15T10:47:05.550000-04:00
2465999,30459796-566c-45e2-9f4e-91806b47f7a6,Q2,WINNING STRATEGIES WASHINGTON,50796,PHLOW CORPORATION,2020,second_quarter,MED,Domestic manufacturing of essential generic medicines; supply chain disruptions and shortages of foreign manufactured medicines,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-15T11:17:36.900000-04:00
2466007,6ab5aa4b-b018-4235-83fa-4ffe4ba48478,Q2,THE PRENDA GROUP LLC,401104543,UV-CONCEPTS,2020,second_quarter,MED,"Emergency response to COVID-19 Pandemic. Assistance to Hospitals / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. CARES ACT HR 748 S 3548","HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE",10000,,0,0,2020-07-15T11:18:26-04:00
2466179,bdf8683d-9d11-4dea-a9b9-4b3f595ce17c,Q2,WINNING STRATEGIES WASHINGTON,50796,RETRACTABLE TECHNOLOGIES INC (RTI),2020,second_quarter,MED,Response to COVID-19,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-15T12:03:04.730000-04:00
2466467,c00cc6db-61b8-438e-88e2-358df6eb35f7,Q2,COMMONWEALTH POLICY SOLUTIONS,401105004,TRISALUS LIFE SCIENCES,2020,second_quarter,MED,"Medical device development for oncology, drug delivery for oncology","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-15T13:49:35.603000-04:00
2466472,6f8884ed-8ed6-4aba-9533-68bd008a5d4c,Q2,COMMONWEALTH POLICY SOLUTIONS,401105004,RARE ACCESS ACTION PROJECT,2020,second_quarter,MED,Reimbursement for rare disease patient care,"HOUSE OF REPRESENTATIVES,SENATE",12000,,0,0,2020-07-15T13:50:37.253000-04:00
2466532,502cc758-2b76-46f5-8223-34e38ab63488,Q2,SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN,35068,SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN,2020,second_quarter,MED,Support recognizing construction activities as essential service during pandemic,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-15T14:10:52.473000-04:00
2466652,40d08ab4-3c39-4435-8b69-13d686863344,Q2,NEOGENOMICS LABORATORIES,401105014,NEOGENOMICS LABORATORIES,2020,second_quarter,MED,"Verifying Accurate Leading-Edge IVCT Development Act (VALID Act), Draft Legislation","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2020-07-15T14:38:16.733000-04:00
2466654,f4009bc0-245a-4252-9a8a-01fc9058892e,Q2,"THE CONAFAY GROUP, LLC",401004840,"HAWAII BIOTECH, INC.",2020,second_quarter,MED,Medical countermeasures.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2020-07-15T14:39:17.903000-04:00
2466884,9f9ee02b-d97a-4a21-bcb9-c0a5de251955,Q2,GREEN PLAINS INC.,401104765,GREEN PLAINS,2020,second_quarter,MED,"Issues related to the Novel Coronavirus and the disease COVID-19; Issues related to the production of industrial grades of alcohol for inclusion in hand sanitizer; Issues related to the transportation and tax treatment for industrial grades of alcohol for inclusion in hand sanitizer; H.R. 748, the CARES Act; H.R. 6800, the Heroes Act;","Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Federal Emergency Management Agency (FEMA),Federal Motor Carrier Safety Administration,Federal Reserve System,Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office",,180000,0,0,2020-07-15T16:13:18.373000-04:00
2466931,3e0b4a0d-1ceb-4631-b793-16c0561db9e9,Q2,"THE CONAFAY GROUP, LLC",401004840,ACADIA PHARMACEUTICALS INC.,2020,second_quarter,MED,Pharmaceutical research.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2020-07-15T16:25:28.317000-04:00
2466997,ef6d4a13-1b47-4b2f-b092-1b923ce58726,Q2,"THE CONAFAY GROUP, LLC",401004840,EMERGEX VACCINES HOLDING LTD.,2020,second_quarter,MED,Influenza and respiratory disease research,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2020-07-15T16:55:51.483000-04:00
2467002,9575e367-f481-4d6c-94aa-00bd732f21cd,Q2,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,"MOSES WEITZMAN HEALTH SYSTEM, INC.",2020,second_quarter,MED,"Moving Forward Act, H.R. 2
Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, now P.L. 116-136
Families First Coronavirus Response Act, H.R. 6201, now P.L. 116-127
Coronavirus Preparedness and Response Supplemental Appropriations Act, H.R. 6074, now P.L. 116-123
House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bill
House, Senate Financial Services and General Government Appropriations Bill
House, Senate Community Health Center Reauthorization Bills
Pursuit of grants with federal agencies
House, Senate Legislation to to Reauthorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Training Programs and Medical Assistant Training Programs
House, Senate Comprehensive Addiction and Recovery Legislation
House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment
House, Senate Legislation to Fund FCC Broadband and Other Telehealth 
House, Senate Legislation to Train More Primary Care and Other Providers
House Legislation to Implement Electronic Health Provider Consultations (E-Consults) with Related 
Telemedicine in Health Centers and Rural Health Clinics, H.R. 5190 
House, Senate Infrastructure Bills (i.e., H.R. 2, H.R. 2741, H.R. 4780)","Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Telecommunications & Information Administration (NTIA),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",10000,,0,0,2020-07-15T16:57:53.227000-04:00
2467006,f4e251a7-170e-4e47-8d69-aaea1a0f74ab,Q2,"THE CONAFAY GROUP, LLC",401004840,"PREACTIVE TECHNOLOGIES, INC.",2020,second_quarter,MED,Traumatic Brain Injury Prevention,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-15T17:00:54.473000-04:00
2467026,63922695-36b7-4dcf-8960-54501e11e251,2T,"THE CONAFAY GROUP, LLC",401004840,PHLOW CORPORATION,2020,second_quarter,MED,US pharmaceutical manufacturing,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,1,2020-07-15T17:14:58.880000-04:00
2467054,f5ed92db-d68f-40ae-9508-d78544f9d6b0,Q2,"THE CONAFAY GROUP, LLC",401004840,"CIDARA THERAPEUTICS, INC.",2020,second_quarter,MED,Support for research on viral diseases,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2020-07-15T17:38:10.347000-04:00
2467087,62ee4d96-2c83-40cd-9c3b-4030ede3d586,Q2,"THE CONAFAY GROUP, LLC",401004840,"EMERJA, INC. (FORMERLY KNOWN AS WHEEL BIOLOGY, INC.)",2020,second_quarter,MED,Seek support for research and development funding,"Health & Human Services, Dept of (HHS)",10000,,0,0,2020-07-15T17:59:19.810000-04:00
2467098,58f68ea7-2296-4277-a100-7857674add9e,Q2,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,PIH HEALTH FOUNDATION,2020,second_quarter,MED,"Moving Forward Act, H.R. 2
Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, now P.L. 116-136
Families First Coronavirus Response Act, H.R. 6201, now P.L. 116-127
Coronavirus Preparedness and Response Supplemental Appropriations Act, H.R. 6074, now P.L. 116-123
House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bill
House, Senate Department of Homeland Security Appropriations Bill  
House, Senate Department of Agriculture Appropriations Bill 
Pursuit of grants with Federal agencies
Telemedicine
House, Senate Infrastructure Bills (i.e., H.R. 2, H.R. 2741, H.R. 4780)","Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Communications Commission (FCC),Federal Election Commission (FEC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",30000,,0,0,2020-07-15T18:08:21.927000-04:00
2467106,a4198c42-7633-4277-9bf0-63419f01c7c5,Q2,"THE CONAFAY GROUP, LLC",401004840,"LUNGPACER MEDICAL USA, INC",2020,second_quarter,MED,Seek support for research and development funding.,"Health & Human Services, Dept of (HHS)",10000,,0,0,2020-07-15T18:13:24.120000-04:00
2467178,688177c2-c3e0-47ad-a842-2ed67826c1b3,Q2,"MEHLMAN CONSULTING, INC.",284950,AEGIS SCIENCES CORPORATION,2020,second_quarter,MED,"H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136; Provisions related to coverage of diagnostic testing","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2020-07-15T20:05:46.763000-04:00
2467315,3d0f9ac5-26de-48b4-83cf-e1e2526cb8dc,Q2,"PACE, LLP",30495,GLADSTONE INSTITUTE,2020,second_quarter,MED,"Stem cell research for disease and wound treatments
COVID response pollcies","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-16T01:16:20.660000-04:00
2467333,f3d543d1-ec57-463e-a469-1a7f5df59aa8,Q2,AMERICAN SOCIETY OF ADDICTION MEDICINE,401104864,AMERICAN SOCIETY OF ADDICTION MEDICINE,2020,second_quarter,MED,"Advocated for FY2021 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, increase in funding for the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, funding for preventive medicine residency programs, and $8.8 billion for discretionary Health Resources and Services Administration programs.

Supported HR 3414 (and prior versions)/ S. 2892 - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period.

Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits.  Advocated for its inclusion in the Lower Health Care Costs Act of 2019.

Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn.  This bill is not specific to mental health, but it would provide significant stability to those patients and providers. 

Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes.

Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release.

Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration, which is set to end in mid-2019. 

Supported the Parity Enforcement Act (HR 2848). This legislation would give the U.S. Department of Labor authority to levy civil monetary penalties against health insurers and plan sponsors for parity violations of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008.


Supported S.1012/ HR 2062 Protecting Jessica Grubbs Legacy Act/ Overdose Prevention and Patient Safety Act to amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.

Supported HR 4974:  the MATE Act - to amend the Controlled Substances Act to require physicians and other prescribers of controlled substances to complete training on treating and managing patients with opioid and other substance use disorders (which shall also satisfy certain training required to receive a waiver for dispensing narcotic drugs for maintenance or detoxification treatment),and for other purposes.

Supported a conditional endorsement of The Mainstreaming Addiction Treatment Act, which is contingent upon the elimination of DEA regulations on medications in Schedules III-V that are based on the prescribing intent to treat addiction and a requirement that all DEA controlled substance prescribers complete medical education on addiction. 

Supported the Humane Correctional Health Care Act , H.R. 4141/S. 2305, which would repeal the Medicaid Inmate Exclusion. The exclusion strips health coverage from Medicaid enrollees who are involved in the criminal justice system. 

Supported H.R. 3925, the Reducing Barriers to Substance Use Treatment Act, introduced by Representatives Paul Tonko (D-NY) and David McKinley (R-VA). The bill would prohibit state Medicaid programs, beginning in October 1, 2020, and ending September 30, 2025, from imposing prior authorizations or other types of utilization control policies or procedures on medications approved to treat OUD, including, with respect to the provision of those medications, counseling services and behavioral therapy. 

Supported the Reversing the Youth Tobacco Epidemic Act of 2019 (HR 2339) which would, among other things, amend the Federal Food, Drug, and Cosmetic Act with respect to the sale and marketing of tobacco products 

Supported HR 4742, Protecting American Lungs Act, a bill to impose a tax on nicotine used in e-cigarettes.

Supported HR 5632, The FDA Accountability for Public Safety Act, which would require the FDA Commissioner to make the final decision on drug approvals if the advisory committee advises against approval, among other things. 

Advocated for the addiction of a Medicaid Provider Status requirement on any new State Opioid Response Grant funding

Advocated for the use of audio-visual telehealth for initation of new OTP patients to be treated with methadone

Advocated for an increase in the DATA 2000 waiver patient limit

Advocated for telehealth buprenorphine initiation as an exception to Ryan Haight

Advocated for addiction CMS guidance and coverage related to telehealth

Advocated to allow Opioid Treatment Programs (OTPs) to operate mobile units without requiring them to obtain a separate registration as well as more flexibility regarding take-home medications dispensed from an OTP

Advocated for $38.5B in emergency relief funds for mental health disorder and addiction treatment providers as a result of losses suffered due to COVID-19

Advocated for inclusion of provisions in HR 748 of the CARES Act, related to the Opioid Workforce Act, the Reducing Barriers to Substance Use Disorder Treatment, Medicaid Reentry, emergency health care provider relief funds, reform of 42 CFR Part 2, amont other ASAM priorities

Advocated for eventual filing of the Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act (S. 4103).  For purposes of prescribing Schedule III and IV medications, including buprenorphine for the treatment of opioid use disorder, the TREATS Act would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement. The TREATS Act would also clarify Medicares continued ability, beyond the COVID-19 public health emergency, to reimburse for audio-only, substance use disorder telehealth services after an in-person or telehealth evaluation","Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",,70000,0,0,2020-07-16T07:16:27.093000-04:00
2467693,3669f4ab-16bd-433c-a127-4bac57bf1d35,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,MAYO CLINIC,2020,second_quarter,MED,Issues impacting academic medical centers.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2020-07-16T10:41:21.857000-04:00
2467733,374bce5c-19dd-47c7-8809-8c7d2be962de,Q2,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,COLOR HEALTH (FKA COLOR GENOMICS),2020,second_quarter,MED,Lobbying related to healthcare issues.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2020-07-16T10:47:31.067000-04:00
2467832,a1b897ad-33de-4b96-9978-6da148e16ca8,Q2,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,"INTUITIVE SURGICAL, INC.",2020,second_quarter,MED,Lobbying related to health care issues.,SENATE,20000,,0,0,2020-07-16T11:04:57.140000-04:00
2467885,4950397d-04ee-4714-9751-9dba8d93aa2f,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ENDOCRINE SOCIETY,2020,second_quarter,MED,"Research in Endocrinology, Standardization of Hormone Testing
Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) 
Special Diabetes Program","Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2020-07-16T11:14:10.617000-04:00
2467948,1348a79c-aa7b-4bee-9edc-6776bdee273b,Q2,TRAVERE THERAPEUTICS,401104190,TRAVERE THERAPEUTICS,2020,second_quarter,MED,"Medical research, NIH funding, related appropriations issues; House and Senate Labor HHS Appropriations Act; FY 2021 CDC Appropriations related to newborn screening; H.R. 478, CARES Act; H.R. 6800, HEROES Act; kidney treatment and care issues","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,150000,0,0,2020-07-16T11:28:25.487000-04:00
2468104,65fd3394-32df-4252-8862-40357b1f2d9f,Q2,"THE CONAFAY GROUP, LLC",401004840,"NABRIVA THERAPEUTICS US, INC.",2020,second_quarter,MED,Support for medical countermeasure procurement.,"Health & Human Services, Dept of (HHS)",,,0,0,2020-07-16T11:58:10.927000-04:00
2468110,bad03988-a599-44d5-9516-49137d35fe44,Q2,"TWENTY-FIRST CENTURY GROUP, INC.",38687,NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX),2020,second_quarter,MED,Research and treatment related to suicide prevention for veterans and patients with bipolar depression; COVID-19 research and treatment.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-16T11:59:12.140000-04:00
2468137,fc3d44d0-d43d-4773-812b-a723e2ec1d1f,Q2,"TWENTY-FIRST CENTURY GROUP, INC.",38687,"CORNERSTONE PHARMACEUTICALS INC. (FORMERLY RAFAEL PHARMACEUTICALS, INC.)",2020,second_quarter,MED,Issues related to cancer research and treatment.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2020-07-16T12:07:24.160000-04:00
2468178,d234012b-2a1b-4f9c-b63a-0bd4ceb92b30,Q2,MICHIGAN TECHNOLOGICAL UNIVERSITY,25181,MICHIGAN TECHNOLOGICAL UNIVERSITY,2020,second_quarter,MED,Discussed issues of interest related higher education for the COVID-19 pandemic.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)",,60000,0,0,2020-07-16T12:15:31.803000-04:00
2468834,5447bb98-bc4a-4ea8-b5b6-96d77b8b2ee5,Q2,"THE CONAFAY GROUP, LLC",401004840,"ATEA PHARMACEUTICALS, INC.",2020,second_quarter,MED,Support for medical/disease research.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-16T14:15:45.883000-04:00
2468881,1f61fa4c-8c44-44ed-807e-9c2d0ba82a71,Q2,"THE CONAFAY GROUP, LLC",401004840,CENTIVAX,2020,second_quarter,MED,Support for medical/disease research.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-16T14:23:04.677000-04:00
2468928,80b1d3c2-1a86-495e-a54c-adeff13262cc,Q2,"THE CONAFAY GROUP, LLC",401004840,"PHASEBIO PHARMACEUTICALS, INC",2020,second_quarter,MED,Support for medical/disease research.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2020-07-16T14:30:16.870000-04:00
2469305,a4895781-ce67-4c68-8761-c07d2d69a416,Q2,CAPITOL COUNSEL LLC,313715,MASSACHUSETTS BIOTECHNOLOGY COUNCIL,2020,second_quarter,MED,Monitor health and tax legislation pertaining to the biotechnology industry.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-16T15:37:04.017000-04:00
2469318,98c5a1e2-3964-4dcd-aafe-5c766e4f7c2c,Q2,FAEGRE DRINKER BIDDLE & REATH LLP,12631,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2020,second_quarter,MED,Public Health Programs for Infectious and Tropical Disease; Issues related to NIH grant withdrawal for EcoAlliance.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2020-07-16T15:40:07.300000-04:00
2469384,7ed6a92d-e92b-467f-8ec2-231221d34af3,Q2,BURRELL INTERNATIONAL GROUP LLC,401103483,SMALL BIOTECHNOLOGY BUSINESS COALITION,2020,second_quarter,MED,VALID Act and Laboratory Diagnostic Testing,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-16T15:50:29.577000-04:00
2470050,fe66608a-7a06-4df3-bd0b-9dea589692e8,Q2,MICHAEL N. MCCARTY LAW OFFICE PLLC,401104300,AMERICAN MEDICAL TECHNOLOGISTS,2020,second_quarter,MED,"Appropriations to CDC for harmonization of diagnostic laboratory test results; Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; proposed legislation to establish clinical laboratory workforce development initiatives under the Public Health Service Act and other potential legislative vehicles; prospective legislation to regulate in vitro clinical diagnostic tests, including the Verifying Accurate, Leading-edge IVCT Development (VALID) Act (H.R.6102; S.3404); and the Verified Innovative Testing in American Laboratories (VITAL) Act (S.3512); Coronavirus relief and stimulus legislation as it relates to clinical laboratories and medical practices; coronavirus testing supply chain issues.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",10000,,0,0,2020-07-16T18:48:10.317000-04:00
2470251,540876ba-840b-43e2-88db-f99b7a09cbc0,Q2,"WILLIAMS AND JENSEN, PLLC",41454,GLOBAL DOWN SYNDROME FOUNDATION,2020,second_quarter,MED,Support for down syndrome research funding.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-17T05:52:09.007000-04:00
2470311,01513d1f-07dc-4633-a851-77273c1d492a,Q2,"WILLIAMS AND JENSEN, PLLC",41454,BIOBOT ANALYTICS,2020,second_quarter,MED,"General education to advance policies that support wastewater surveillance data analytic technology. Policies impacting U.S. address to the Covid-19 pandemic, including implementation of the H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748 CARES Act, Public Law No: 116-136.","Centers For Disease Control & Prevention (CDC),Environmental Protection Agency (EPA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE,White House Office",30000,,0,0,2020-07-17T07:02:20.810000-04:00
2470320,954b3d8b-691c-4e11-bee8-e8ef6bff182c,Q2,"WILLIAMS AND JENSEN, PLLC",41454,"SANOFI, U.S.",2020,second_quarter,MED,General education about FDA approval policies and NIH research activities.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",50000,,0,0,2020-07-17T07:04:21.767000-04:00
2470323,500c1f4b-dbbf-42d8-ad5c-013973dd2ab0,Q2,"WILLIAMS AND JENSEN, PLLC",41454,VERTEX PHARMACEUTICALS INCORPORATED,2020,second_quarter,MED,General education about FDA approval policies and NIH research activities.,"Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",30000,,0,0,2020-07-17T07:05:22.480000-04:00
2470450,5dbd4380-29fb-435f-aa77-a88016b963ca,Q2,MANATOS & MANATOS,23634,BARBARA ANN KARMANOS CANCER INSTITUTE,2020,second_quarter,MED,PPS-exempt cancer hospitals,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2020-07-17T09:11:59.170000-04:00
2470533,071c24a6-0bcd-4729-89fa-e655d52437f3,Q2,"TWENTY-FIRST CENTURY GROUP, INC.",38687,GLOBAL ALZHEIMER'S PLATFORM FOUNDATION,2020,second_quarter,MED,Inform Congress about the impact of COVID-19 on Alzheimer's clinical trials.,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2020-07-17T09:30:16.150000-04:00
2470589,a3d747b6-3fbf-41c6-9893-e82aa802180b,Q2,BRACEWELL LLP,6837,NATIONAL BRAIN TUMOR SOCIETY,2020,second_quarter,MED,work related to the advancement of the Cancer Drug Coverage Parity Act and PCHETA (H.R. 647); Peer-review cancer research; Drug pricing and shortages; COVID-19 Response Issues,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2020-07-17T09:47:29.663000-04:00
2470687,fd4050dc-b39b-406b-bd0b-aa3e42204947,Q2,"EFB ADVOCACY, LLC",401104430,UNITED FOR MEDICAL RESEARCH,2020,second_quarter,MED,Funding Issues Related to the National Institutes of Health,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-17T10:05:49.977000-04:00
2471079,23a68576-3663-49a1-bc71-ec5652fd3966,Q2,"OAK RIDGE ASSOCIATED UNIVERSITIES, INC.",401104196,"OAK RIDGE ASSOCIATED UNIVERSITIES, INC.",2020,second_quarter,MED,"NIH funding for aging science, tobacco and peer review activities","Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2020-07-17T11:16:20.840000-04:00
2471175,cd60bfd0-4101-4284-a6fc-b981da0feed8,Q2,FAEGRE DRINKER BIDDLE & REATH LLP,12631,DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA,2020,second_quarter,MED,Issues related to anti-microbial resistance and neglected tropical diseases; CURES 2.0 legislative initiative; Access and affordability of COVID-19 treatments and vaccines; Draft PASTEUR Act legislation.,,10000,,0,0,2020-07-17T11:30:42.790000-04:00
2471180,b5fbeb44-7f88-4022-a2fc-f822d426dfae,Q2,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH,2020,second_quarter,MED,Cures 2.0.; PASTEUR Act legislative draft.,,10000,,0,0,2020-07-17T11:31:44.433000-04:00
2471308,7ae74f67-7343-4ea1-b6d4-0b65a7e2dde7,Q2,ALLIANCE FOR RETIRED AMERICANS,67238,ALLIANCE FOR RETIRED AMERICANS,2020,second_quarter,MED,"1. S. 3847, COVID-19 Emergency Manufacturing Act of 2020, entire bill","Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Pension Benefit Guaranty Corporation (PBGC),Pension & Welfare Benefits Administration,SENATE,Social Security Administration (SSA),U.S. Trade Representative (USTR)",,80000,0,0,2020-07-17T11:52:19.267000-04:00
2471443,c393b01b-01b8-4aac-b7e8-70bf9a997b25,Q2,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2020,second_quarter,MED,"Support for robust funding for federal agencies that fund medical and disease research 
Support for increased federal funding for research and response efforts in response to COVID-19","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE",,70000,0,0,2020-07-17T12:07:48.827000-04:00
2471554,64962912-bf5b-4a2f-93c7-44cc0cbbb08c,Q2,DLA PIPER LLP (US),76855,AMERIHEALTH CARITAS,2020,second_quarter,MED,"Legislative and regulatory proposals affecting Medicaid Managed Care organizations.
Medicaid extenders.
Legislative proposals to respond to the coronavirus pandemic.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2020-07-17T12:19:19.263000-04:00